Under severe clinical conditions, significantly higher HE4 concentrations (P = 0.0007) were measured in those survivors who remained longer at hospital (≥ 10 days), while critically ill COVID-19 with higher HE4 levels (P = 0.1653) died earlier with shorter hospital stay (Fig. 2A). This evidence concerns the gene WFDC2 and COVID-19.